Concomitant administration of a bivalent Haemophilus influenzae type b-hepatitis B vaccine, measles-mumps-rubella vaccine and varicella vaccine: safety, tolerability and immunogenicity.

@article{Hesley2004ConcomitantAO,
  title={Concomitant administration of a bivalent Haemophilus influenzae type b-hepatitis B vaccine, measles-mumps-rubella vaccine and varicella vaccine: safety, tolerability and immunogenicity.},
  author={Teresa M. Hesley and Keith S. Reisinger and Bradley J Sullivan and Erin H Jensen and Susan Stasiorowski and Cathy Meechan and Christina Y Chan and David J. West},
  journal={The Pediatric infectious disease journal},
  year={2004},
  volume={23 3},
  pages={240-5}
}
BACKGROUND The study was done to verify that concomitant administration of a bivalent Haemophilus influenzae type b-hepatitis B vaccine (Comvax), measles-mumps-rubella vaccine (M-M-RII) and varicella vaccine (Varivax) would be well-tolerated and suitably immunogenic with respect to all vaccine antigens. METHODS We randomized 822 healthy 12- to 15-month-old children (1:1) to receive concomitant injections of Comvax, M-M-RII and Varivax (concomitant group) or Comvax followed 6 weeks later by… CONTINUE READING